Impact of 12-Month Angioscopic Thrombi and Yellow Plaque After Drug-Eluting Stent Implantation

Masami Nishino; Yasuyuki Egami; Hiroaki Nohara; Shodai Kawanami; Kohei Ukita; Akito Kawamura; Koji Yasumoto; Naotaka Okamoto; Yasuharu Matsunaga‐Lee; Masamichi Yano; Tatsuya Shiraki; Daisuke Nakamura; Isamu Mizote; Takayuki Ishihara; Toshiaki Mano; Takafumi Ueno; Daisaku Nakatani; Shungo Hikoso; Shinsuke Nanto; Yasushi Sakata

doi:10.1253/circj.cj-24-0255

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Coronary angioscopy (CAS) has 2 unique abilities: direct visualization of thrombi and plaque color. However, in the recent drug-eluting stent (DES) era, serial CAS findings after DES implantation have not been fully elucidated. We investigated the impact of CAS findings after implantation of a polymer-free biolimus A9-coated stent (PF-BCS) or durable polymer everolimus-eluting stent (DP-EES).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Nishino et al. (2024) studied this question.

synapsesocial.com/papers/68e60bf4b6db64358759f0da https://doi.org/10.1253/circj.cj-24-0255

View Full Paper

Ask AI

Bookmark

Share

Impact of 12-Month Angioscopic Thrombi and Yellow Plaque After Drug-Eluting Stent Implantation

Ask about this paper

Abstract

Discussion

Cite This Study

Impact of 12-Month Angioscopic Thrombi and Yellow Plaque After Drug-Eluting Stent Implantation

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading